Meta‐Analysis: High anti‐ HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment

Documenti analoghi

• Editorial: HBeAg ‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations
  di: Ying‐Nan Tsai, et al.
  Pubblicazione: (2025)
• Favourable Prognosis of Patients With Untreated HBeAg‐Negative Chronic Hepatitis B Virus Infection With HBsAg < 100 IU/mL
  di: Jian Wang, et al.
  Pubblicazione: (2024)
• Editorial: HBeAg ‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations. Authors' Reply
  di: Yuxin Chen, et al.
  Pubblicazione: (2025)
• Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply
  di: Jian Wang, et al.
  Pubblicazione: (2025)
• Letter: Using Anti‐ HBs Titres to Tailor HBV Reactivation Monitoring in Patients With Solid Tumours
  di: Tsutomu Nishida, et al.
  Pubblicazione: (2026)